SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-16-000042
Filing Date
2016-02-05
Accepted
2016-02-05 16:10:05
Documents
56
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12311510-q.htm 10-Q 1005509
2 EXHIBIT 10.1 a12312015ex101.htm EX-10.1 808911
3 EXHIBIT 31.1 a12312015ex311.htm EX-31.1 14723
4 EXHIBIT 31.2 a12312015ex312.htm EX-31.2 13992
5 EXHIBIT 32.1 a12312015ex321.htm EX-32.1 11736
12 ex18.jpg GRAPHIC 12777
13 ex129.jpg GRAPHIC 17246
  Complete submission text file 0001100412-16-000042.txt   6141991

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arry-20151231.xml EX-101.INS 1090370
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20151231.xsd EX-101.SCH 36139
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20151231_cal.xml EX-101.CAL 57199
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20151231_def.xml EX-101.DEF 211025
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20151231_lab.xml EX-101.LAB 559174
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20151231_pre.xml EX-101.PRE 335320
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 161392304
SIC: 2834 Pharmaceutical Preparations